chr11-114571345-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001077639.2(NXPE4):āc.1228G>Cā(p.Val410Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000682 in 1,613,886 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001077639.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NXPE4 | NM_001077639.2 | c.1228G>C | p.Val410Leu | missense_variant | 6/6 | ENST00000375478.4 | NP_001071107.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NXPE4 | ENST00000375478.4 | c.1228G>C | p.Val410Leu | missense_variant | 6/6 | 1 | NM_001077639.2 | ENSP00000364627.3 | ||
NXPE4 | ENST00000424261.6 | c.376G>C | p.Val126Leu | missense_variant | 6/6 | 1 | ENSP00000401503.2 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152136Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000161 AC: 4AN: 248452Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 134868
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461750Hom.: 0 Cov.: 49 AF XY: 0.00000275 AC XY: 2AN XY: 727184
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152136Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74312
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 19, 2023 | The c.1228G>C (p.V410L) alteration is located in exon 6 (coding exon 5) of the NXPE4 gene. This alteration results from a G to C substitution at nucleotide position 1228, causing the valine (V) at amino acid position 410 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at